Objective: Elite controllers, defined as persons maintaining undetectable levels of HIV-1 replication in the absence of antiretroviral therapy, represent living evidence that sustained, natural control of HIV-1 is possible, at least in relatively rare instances. Understanding the complex immunologic and virologic characteristics of these specific patients holds promise for inducing drug-free control of HIV-1 in broader populations of HIV-1 infected patients.
Introduction
Elite controllers, a rare group of HIV-1 infected individuals (typically <1%) who maintain extremely low or undetectable levels of HIV-1 replication in the absence of antiretroviral therapy, may represent the closest possible approximation to a long-term remission or cure of HIV-1 infection [1] . Despite extremely low plasma HIV-1 RNA levels, these patients harbour clearly detectable populations of virally infected cells and can readily transmit virus to other individuals [2] [3] [4] . Prior studies have investigated a wide spectrum of host factors that may contribute to this remarkable phenotype, but failed to identify a unifying immune mechanism that is universally responsible for viral control in these patients. In part, this may be due to a constitutive heterogeneity among elite controllers, who may include multiple distinct subgroups characterized by discrete mechanisms of viral control [5, 6] . Nevertheless, empiric evidence from genome-wide association studies and other immunogenetic association studies, along with functional immunologic investigations and experimental animal data clearly suggest that cytotoxic T cells can have a profound impact on natural HIV-1 immune control, and arguably represent the best correlate of immune protection against HIV-1 disease progression [6] [7] [8] [9] [10] [11] [12] [13] [14] . CD8 þ T cells can recognize viral peptide/major histocompatibility complex (MHC) class I complexes and execute a variety of antiviral effector functions to restrict viral replication. Notably, a number of prior studies described significant qualitative differences between HIV-1 specific T-cell responses from controllers and progressors, and suggested that continuously ongoing viral replication in progressors drives T cells into an exhausted state, characterized by upregulation of inhibitory cell surface markers, defective proliferative activities, shortened telomeres and reduced expression of perforin, granzyme B and the Th1 signature transcription factor T-bet [15] [16] [17] [18] [19] [20] [21] [22] [23] . Yet, most of these prior studies were biased towards specific predefined molecules or hypotheses, and did not allow for analysis of holistic and global characteristics distinguishing CD8 þ T cells from individuals with natural control of HIV-1 infection. In the present study, we conducted unbiased microarraysupported transcriptional profiling studies of cytotoxic CD8 þ T cells in a large cohort of HIV-1 elite controllers, in comparison to HIV-1 negative persons and individuals with pharmacological viral suppression.
Materials and methods
Patients HIV-1-infected elite controller study participants (n ¼ 51) and HIV-1 negative control persons (n ¼ 10) were recruited from the Massachusetts General Hospital and the Brigham and Women's Hospital (both in Boston, Massachusetts, USA). The definition of elite controller varies widely in HIV-1-infected patient cohorts [24] . However, the definition used for inclusion of elite controller patients in this study is as follows: undetectable viral load using commercially available HIV-1 plasma PCR assays (usually <50 or <75 copies/ml) on at least two consecutive occasions, in the absence of treatment with antiretroviral agents for at least 2 years. Occasional HIV-1 RNA levels above the detection threshold remained always < 200 copies/ml and were allowed as long as subsequent measurements were below the threshold on at least two consecutive occasions. Peripheral blood mononuclear cell (PBMC) samples were used according to protocols approved by the local Institutional Review Board. Study participants gave written informed consent to participate in accordance with the Declaration of Helsinki. In addition, previously described HIV-1 infected study participants treated with suppressive highly active antiretrovial therapy (HAART) (n ¼ 32) were used for this analysis [25] . Demographical characteristics of all the study participants are summarized in Table S1 and S2, http://links.lww.com/QAD/B362.
Isolation of CD8
R T cells from peripheral blood mononuclear cell CD8 þ T cells were isolated from PBMC of patient samples using an automated magnetic cell enrichment device (autoMACS Pro; Human CD8þ T cell isolation kit (Cat. No. 130-096-495); Miltenyi Biotec, Germany).
Isolated CD8
þ T cells routinely reached more than 95% purity. Samples from all cohorts were processed simultaneously for microarray analysis.
Transcriptional profiling (mRNA) using microarray analysis Following mRNA extraction from the sorted cells (mirVana miRNA Isolation Kit, Ambion (Cat. No. AM1560); ThermoFisher Scientific, USA), wholegenome transcriptional profiling was performed using Illumina HumanHT-12 V4 microarrays (Illumina Inc., San Diego, California, USA) according to standard protocols. Data retrieved from the Illumina software were background corrected (Illumina beadstudio software; Illumina Inc.) and quantile normalized using the Arraystar normalization function. Subsequent data analysis was restricted to genes with significant expression (P < 0.05) in at least 95% of samples. The microarray dataset was deposited to GEO (accession number GSE87620).
Data analysis
Differentially expressed genes were identified using the R/Bioconductor package, LIMMA, with a cut-off false discovery rate (FDR)-adjusted P value of less than 0.05 and fold change more than 1.5-fold [26] . First and second components from principal component analysis (PCA) were used to demonstrate the similarity/difference of expression patterns among all samples. Differentially expressed genes were subjected to unsupervised hierarchical clustering analysis and visualized using heatmaps and volcano plots, using R [27] . Identification of canonical pathways, diseases and functions, as well as roles of upstream regulators of differentially expressed genes were determined by Ingenuity Pathway Analysis (IPA; QIAGEN Inc., Germantown, Maryland, USA) and subsequently visualized using GraphPad Prism for Mac (GraphPad Software, La Jolla, California, USA). Functional annotations of the differentially expressed genes were also determined using the Database for Annotation, Visualization and Integrated Discovery or DAVID [28, 29] . Gene ontology of the biological processes was subsequently visualized using REVIGO [30] . To identify subgroups of elite controllers, we performed a bootstrapping analysis with 1000 hierarchical clustering permutations, each consisting of 500 transcripts randomly selected out of to the total pool of 4921 transcripts that were detectable in at least 49 (96%) elite controllers. Patients clustering with each other in more than 60% of these permutations were assigned to identical subgroup.
Results

Distinct transcriptional signatures of CD8
R T cells from HIV elite controllers Cytotoxic T cells have repeatedly been identified as a predominant correlate of HIV-1 immune control, but distinct molecular signatures most closely associated with effective antiviral activity of CD8 þ T cells remain an area of remarkable uncertainty [5] [6] [7] 31, 32] . Individuals with natural control of HIV-1 replication to low or undetectable levels arguably represent the most informative patient cohort for characterizing protective CD8 þ T cells, but relatively small sample sizes, combined with a narrow and exclusive focus on antigen-specific cells in prior studies may have limited investigative power to detect discrete transcriptional profiles of CD8 þ T cells in this specific patient population [16, 17, [33] [34] [35] [36] . To address this, we conducted a detailed analysis of genome-wide transcriptional programs of CD8 þ T cells from a large cohort of elite controllers (n ¼ 51), using unbiased microarray-based transcriptional profiling. HIV-1 patients treated with suppressive HAART (n ¼ 32), as well as a cohort of HIV-1 uninfected, healthy individuals (n ¼ 10) were recruited for comparative purposes.
This global comparison of gene expression patterns in CD8
þ T cells demonstrated profound differences between HAART-treated patients and elite controllers, with a total of 590 genes that were differentially expressed between these two cohorts using robust statistical criteria (FDR-adjusted P < 0.05, fold-change difference in gene expression >1.5) (Fig. 1a) . Gene expression profiles between elite controllers and HIV-1 negative individuals were remarkably similar, and displayed not a single transcript meeting the definition for differential gene expression, highlighting that CD8 þ T-cell transcriptional profiles from these two study cohorts were essentially HIV-1 elite controller CD8 R T transcriptome Chowdhury et al. 2671 The plot generated using REVIGO reflects clustering of semantic similarities between GO terms of Biological Processes as determined by DAVID. Colour coding corresponds to log 10 (P) of GO terms in differentially expressed genes, also determined using DAVID. Terms with high functional relevance for CD8 þ T cell biology are highlighted.
indistinguishable. In contrast, a total of 47 transcripts were differentially expressed between HIV-1 negative and HAART treated patients ( Fig. 1a and Figure S1 , http:// links.lww.com/QAD/B362). PCA and a hierarchical clustering analysis confirmed considerable differences in global gene expression patterns between elite controllers and HAART-treated persons, while transcriptional profiles of HIV-1 negative individuals appeared to intermingle between these two study cohorts (Fig. 1b, c) . Notably, transcripts that were differentially expressed between HIV-1 negative individuals and HAART-treated persons almost entirely overlapped with genes that differed between elite controllers and HAART-treated patients, and the directional expression profiles of these 40 transcripts (encoding for 34 mapped genes functionally involved in cell death, proliferation, differentiation and cytokine response) were almost identical in both comparisons; this suggests that these 40 transcripts represent a molecular signature unique to HAART-treated persons (Fig. 1d, e) . Together, these data demonstrate distinct global gene expression patterns of CD8 þ T cells in HIV-1 patients with immunological control of HIV-1 infection, compared with those with pharmacological control of HIV-1 infection.
Metabolic pathways distinguish transcriptional signatures of elite controllers
We subsequently focused on a closer analysis of the transcripts distinguishing elite controllers from HAARTtreated patients. Out of the 590 transcripts with different expression between elite controllers and HAART-treated patients, a total of 342 were upregulated and 248 were downregulated in elite controllers (Fig. 2a) þ T cells from EC and HAART-treated patients (FDR-adjusted P < 0.05, fold change >1.5). (b) Predicted biological functions of genes differentially expressed between EC and HAART-treated patients, as determined using Ingenuity Pathway Analysis (IPA). Dotted line depicts the threshold -log (P) of 1.3 or P 0.05. Z-scores reflect predicted directional changes of genes function, positive z-score corresponds to functional activation, while negative z-score reflects functional deactivation. (c) Upstream cytokines predicted to account for transcriptional differences between EC versus HAART-treated patients. Dotted line depicts the threshold -log (P) of 1.3 or P 0.05. (d) Canonical pathways enriched in differentially regulated genes between EC and HAART, as determined using IPA. The right y-axis reflects the ratio between the number of differentially expressed genes that map to a particular pathway divided by the total number of genes curated to that pathway. Dotted line depicts the threshold -log (P) of 1.3 or P 0.05. (e) Gene ontology (GO) analysis of the 590 differentially expressed transcripts between EC and HAART samples. The REVIGO plot reflects clustering of semantic similarities between the biological GO terms and is colour coded according to log 10 (P) of the GO term as determined using DAVID analysis of the identified genes within the list of 590 transcripts.
effect analysis using IPA predicted that transcripts related to protein synthesis and metabolism, and genes involved in viral RNA replication and infection were enriched in elite controllers, while transcripts related to cell death and necrosis were repressed in these patients (Fig. 2b) . Upstream regulators computationally inferred to govern the distinct transcriptional profile of CD8 þ T cells from elite controllers included the common gamma-chain cytokines interleukin (IL)-2, IL-7 and IL-15, as well as the inflammatory cytokines tumour necrosis factor-alpha (TNF-a and IL-1b (Fig. 2c) . We subsequently entered differentially expressed transcripts from elite controllers into a weighed IPA analysis able to computationally translate altered gene expression patterns into directional changes of canonical biological pathways. These investigations demonstrated that CD8 þ T cells from elite controllers exhibited activation of closely related metabolic pathways centred around the eukaryotic initiation factor 2 (eIF2), the mammalian target of rapamycin (mTOR) and phosphoinositide-3-Kinases (PI3K). mTOR, a downstream effector of PI3Ks, acts as a nutrient and oxygen sensor and can exert critical influence on cellular gene translation, in part through modulation of eIF2 (Fig. 2d) . Notably, transcripts involved in oxidative stress and hypoxia, regulated at least partially by mTOR, were also increased in elite controllers. In line with these findings, metabolic activation, protein synthesis, and TCR signalling were inferred as differentially regulated pathways in elite controllers by alternative computational gene ontology prediction tools (Fig. 2e and Figure S2 , http://links.lww.com/QAD/B362). Previous reports also suggest an important influence of metabolic control pathways on CD8
þ T-cell function [34, 37, 38] .
Unbiased transcriptional profiling identifies distinct subgroups of elite controllers Elite controllers are operationally defined by low or undetectable viral loads, but numerous studies suggest that they may represent a heterogeneous group of patients with distinct underlying mechanisms of immune control [39] . To identify possible transcriptional differences between subgroups of elite controllers, a bootstrapping approach was chosen, based on 1000 hierarchical clustering permutations of 500 randomly selected transcripts. Patients clustering with each other in more than 60% of these permutations were assigned to identical subgroups. Using this analytic strategy, we were able to categorize 49 members of our elite controllers cohort to one of five different subgroups, termed EC1-EC5 in this HIV-1 elite controller CD8 R T transcriptome Chowdhury et al. 2673 manuscript, whose gene expression signatures were clearly distinguishable using a hierarchical clustering approach (Fig. 3a) and by PCA (Fig. 3b) . The numbers of transcripts that were differentially expressed between these subgroups of elite controllers ranged from 564 to 3327, and were highest for intersubgroup comparisons with EC5, the smallest of all elite controllers subgroups identified (Fig. 3c) . EC5 showed also the most striking transcriptional differences in comparison to HAARTtreated individuals and HIV-1 negative persons, followed by EC3 and EC1; EC2 and EC4 showed comparatively minor differences relative to HAART-treated patients (Fig. 3c, d) . A similar pattern was noted in comparison to HIV-1 negative individuals, with EC5, EC3 and EC1 displaying the most profound transcriptional differences to this reference group (Fig. 2c, e) . Notably, despite the marked gene expression changes between these elite controllers subgroups, we noted that patients' age, the duration of HIV-1 infection, the ratio of CD4 þ :CD8 þ cells or total CD4 þ cell counts, the neutralizing breadth of HIV-1 specific antibodies or the breadth and magnitude of HIV-1-specific CD8 þ T-cell or cytotoxic T-lymphocyte (CTL) responses determined by interferon-gamma ELISpot assays were not significantly different between the different subgroups ( Figure S3 , http://links.lww.com/QAD/B362). In addition, the expression intensity of the immune checkpoint molecules Tim-3, LAG3 and PD-1 did not markedly differ among total CD8 þ T cells from the detected subgroups of elite controllers ( Figure S4B , http://links.lww.com/QAD/ B362), despite the distinct expression profile of such markers previously observed on HIV-1 specific CD8 þ T cells from controllers [40, 41] . However, CTLA4 expression was slightly, albeit significantly, increased in HIV-1 negative individuals when compared with CD8 þ T cells from total elite controllers and the EC4 subgroup ( Figure  S4A , S4B, http://links.lww.com/QAD/B362).
Transcriptional signatures of mammalian target of rapamycin and eIF2 in elite controllers subgroups To more closely analyse the functional differences between these elite controllers subgroups, we focused on transcripts that distinguished elite controller subgroups from either HIV-1 negative study individuals, HAARTtreated control patients or both reference cohorts, and selectively entered these transcripts into a predictive canonical pathway analysis supported by IPA. This analysis demonstrated that transcripts involved in translational control by eIF2, eIF4, p70S6K and mTOR signalling pathways, previously identified as key functional regulators distinguishing the elite controllers cohort as a whole from the HAART-treated samples (Fig. 2d) , were most clearly detectable in EC1 (Fig. 3f) . However, relative to the control cohorts, mTOR and eIF signalling pathways were also predicted to be significantly involved in all other elite controllers subgroups, except for EC2 (Fig. 4a, b ). Yet, individual gene members of the eIF2 and mTOR signalling pathways frequently showed strikingly different, and sometimes opposing gene expression patterns between the EC subgroups, consistent with discrete activation and deactivation of eIF2/ eIF4/mTOR pathway members in elite controllers subgroups (Fig. 4b-e) . These observations support the role of eIF2 and mTOR-governed metabolic pathways as distinguishing features of CD8 þ T cells from elite controllers, but highlight considerable variations in metabolic pathway regulation between the elite controller subgroups, potentially involving receptor downstream intermediates such as PI3K/AKT or p38 signalling (Fig. 4e) . Moreover, each of the analyzed gene expression signatures from elite controller subgroups were associated with distinct, although partially overlapping functional annotations (Fig. 4f, g ). For instance, signatures of EC3 and EC5 seemed to be enriched for transcripts related to T cell maturation, activation, proliferation, as well as CTL cytotoxicity, as opposed to EC2 in whom these functions were less obvious (Fig. 4f-h ). In addition, EC2 showed predicted signatures of increased cell death (Fig. 4h) , while EC1, EC3 and EC5 were enriched for transcripts predicted to induce cell survival and viability (Fig. 4g, h ). These data suggest that discrete transcriptional profiles of CD8 þ T cells in elite controllers subgroups may contribute differentially to HIV-1 immune control in elite controller subgroups.
Discussion
HIV-1 infection can lead to drastically different clinical outcomes, ranging from elite controllers with a functional cure of HIV-1 infection to persons with rapid progression to clinical immune deficiency and death. How natural, drug-free control of HIV-1 replication can be achieved seems to vary considerably among different individuals, but CD8 þ T cells represent the immune compartment most frequently invoked in HIV-1 immune control in humans, and most definitively validated as correlates of simian immunodeficiency virus (SIV) immune protection in SIV-infected animals. Antiretroviral effects of CD8 þ T cells have been mostly attributed to the small subset of HIV-1 specific CD8 þ T cells, which can be detected and visualized by intracellular cytokine staining or MHC class I tetramers [32, [42] [43] [44] . These cells can recognize cognate HIV-1 peptides presented by MHC class I complexes and execute antiviral effector functions upon antigen stimulation. However, increasing evidence suggest that antiviral effects of CD8 þ T cells may not be restricted to the HIV-1 specific CD8 þ T cells, but more broadly involve the entire CD8 þ T-cell compartment. For instance, elegant studies by Cartwright et al. [45] demonstrate that depletion of total CD8 þ T cells in ART-treated SIV-infected rhesus macaques leads to blips of viremia, arguably resulting from reignition of viral replication that is otherwise suppressed by CD8 þ T cells.
Moreover, work by Nishimura et al. [46] showed that treatment of SIV-infected rhesus macaques with broadly neutralizing antibodies can induce a CD8 þ T-cell mediated form of viral immune control. In the present work, we have interrogated the entire CD8 þ T-cell compartment of a large cohort of elite controllers, using a transcriptional profiling approach. Surprisingly, these studies failed to reflect a specific antiviral effector profile of CD8 þ T cells in elite controllers, but instead identified a distinct programme of signalling networks governed by PI3K/AKT, mTOR and eIF2, an interconnected family of cellular signal transduction molecules with critical roles for regulating cellular growth, proliferation and metabolism, as distinguishing aspects of CD8 þ T cells from elite controllers. Notably, mTOR has also been shown to play a pivotal role in controlling HIV transcription and latency in CD4 þ T cells, and pharmaceutical inhibitors of the mTORC1 subcomplex such as rapamycin/sirolimus protect against a variety of age-related diseases, leading to extended lifespan in model organisms [47] [48] [49] [50] .
Remarkably, sirolimus is currently evaluated as a modulator of antiviral immune responses and viral reservoir sizes in HIV-1 infected patients in a multicentre study, and such an interventional study may allow to more specifically identify mechanisms by which mTOR modulation may contribute to natural control of HIV-1 (ClinicalTrials.gov Identifier: NCT02440789). Although we found that mTORassociated transcripts were altered in the vast majority of elite controllers relative to the control cohorts, we noted that directional gene expression patterns of such transcripts varied considerably among elite controller subgroups, suggesting distinct effects of the mTOR signalling pathway in subgroups of such patients. Future comparisons of mTOR-associated transcriptional signatures in elite controller and HAART-treated HIV-1 patients undergoing treatment with sirolimus may allow to delineate possible therapeutic benefits of mTORC1 inhibition during HIV-1 infection, and help to identify optimized biomarkers of metabolic and immunologic changes associated with sirolimus therapy.
HIV-1 elite controller CD8
R T transcriptome Chowdhury et al. 2675 þ T-cell functions were predicted using differentially expressed genes between indicated EC subgroups and HAART-treated patients or HIV-1 negative donors. Heat maps show P (f) and Z-scores (g) of selected CD8 þ T-cell functions determined using IPA. Grey segments represent a lack of value as determined using IPA or a lack of significant differentially expressed transcripts in input for IPA analysis. (h) Comparative analysis of the relevant functions in EC2, EC3 and EC5. The radar plot depicts predicted upregulation (positive zscore) or downregulation (negative z-score) of the selected functions in indicated EC subgroups, as determined using IPA analysis.
An important finding of this study is the transcriptional heterogeneity in CD8 þ T cells from elite controllers. This observation corresponds well to a series of prior studies highlighting marked immunological differences among elite controllers, despite a seemingly identical clinical phenotype defined by undetectable levels of viral replication in the absence of antiretroviral therapy [5, 6] . In fact, previous studies have identified diverse groups of elite controller subgroups based on the presence or absence of protective HLA class I alleles, the magnitude and functionality of HIV-1 CD8 þ T cells, the susceptibility of CD4 þ T cells to HIV-1 in ex-vivo infection assays and the transcriptional signatures of CD4 þ T cells [5, 6, 39] . Together with the findings reported here, these results strongly suggest that natural control of HIV-1 in the absence of treatment is likely a result of combinations of different immune mechanisms that may directly or indirectly contribute to restriction of HIV-1 replication. In the future, a systematic parallel assessment of transcriptional gene expression patterns, virological reservoir parameters, immune phenotypes and functions and epigenetic profiles in large numbers of elite controllers may be necessary to detect more comprehensive, multifaceted characteristics that distinguish elite controllers, and mechanistically contribute to antiviral immune control. Moreover, use of improved techniques such as single-cell RNA-seq [51] may allow for a more personalized, 'precision medicine'-oriented approach for identifying individual components of immune protection in elite controllers. Given the considerable morbidity that HIV-1 continues to exert worldwide, despite improved availability and access to potent antiretroviral therapy, such a large-scale effort to characterize elite controllers may represent a promising approach to identify and, ultimately, induce mechanisms of natural HIV-1 control in broader populations of patients.
